TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma.

Pedro Barata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.